Aqr Capital Management LLC Agenus Inc Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.53 - $0.93 $385,708 - $676,808	727,751 Added 157.66%	1,189,336 $689,000
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $290,798 - $526,206	461,585 New	461,585 $383,000
Q2 2023 Aug 14, 2023	SELL	$1.31 - $2.04 $115,408 - $179,719	-88,098 Reduced 81.36%	20,180 $32,000
Q1 2023 May 15, 2023	SELL	$1.45 - $2.95 $97,031 - $197,408	-66,918 Reduced 38.2%	108,278 $164,000
Q4 2022 Feb 14, 2023	SELL	$2.02 - $3.25 $973,337 - $1.57 Million	-481,850 Reduced 73.34%	175,196 $420,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $979,541 - $1.57 Million	-499,766 Reduced 43.2%	657,046 $1.35 Million
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.64 $826,532 - $1.68 Million	635,794 Added 122.03%	1,156,812 $2.24 Million
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $459,631 - $678,690	-195,588 Reduced 27.29%	521,018 $1.28 Million
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $1.72 Million - $3.39 Million	590,518 Added 468.34%	716,606 $2.31 Million
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $627,918 - $835,963	126,088 New	126,088 $662,000
Q1 2021 May 17, 2021	SELL	$2.69 - $5.25 $91,142 - $177,880	-33,882 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.17 - $4.49 $119,043 - $168,612	-37,553 Reduced 52.57%	33,882 $108,000
Q3 2020 Nov 16, 2020	SELL	$2.98 - $5.2 $51,309 - $89,533	-17,218 Reduced 19.42%	71,435 $286,000
Q2 2020 Aug 17, 2020	SELL	$2.29 - $4.24 $10,783 - $19,966	-4,709 Reduced 5.04%	88,653 $348,000
Q1 2020 May 15, 2020	BUY	$1.92 - $4.39 $42,024 - $96,088	21,888 Added 30.62%	93,362 $229,000
Q4 2019 Feb 14, 2020	BUY	$2.41 - $4.4 $99,048 - $180,835	41,099 Added 135.31%	71,474 $291,000
Q3 2019 Nov 14, 2019	BUY	$2.17 - $3.14 $65,913 - $95,377	30,375 New	30,375 $78,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account